Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

1 Dec 1999

Abstract excerpt

OBJECTIVE: To investigate the rate of decline of drug resistant viruses after stopping therapy. DESIGN: Twenty-five patients receiving multiple combination therapies (mean five; range three to nine drugs) for more than 3 months were tested for HIV-1 resistance on therapy and off therapy. The sample off therapy was tested 6-175 days after stopping therapy. METHODS: Patients were tested for genotypic changes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV-related health complications and treatments
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10207561
DOI: 10.1097/00002030-199912240-00001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapyPMID 10207561Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.Semantic proximity Read ↗

Reversal periods and patterns from drug-resistant to wild-type HIV type 1 after cessation of anti-HIV therapy.Semantic proximity Read ↗

Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy.Semantic proximity Read ↗

In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.Semantic proximity Read ↗

Determinants of HIV drug resistance mutations in plasma virus after treatment interruption.Semantic proximity Read ↗

Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.Semantic proximity Read ↗

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.Semantic proximity Read ↗

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.Semantic proximity Read ↗

Use of HIV resistance testing after prolonged treatment interruption.Semantic proximity Read ↗

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.Semantic proximity Read ↗

Clinical implications of stopping nevirapine‐based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistanceSemantic proximity Read ↗

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.